These pathways may influence pain through various mechanisms: altered cortisol secretion affecting stress response and pain modulation; insulin resistance impairing neural glucose utilization and increasing pain sensitivity; and dyslipidemia altering neural membrane composition and signal transduction (53, 54, 56). This evidence concerns the gene INS and metabolic syndrome.